Explore
Validate
Learn16828-1-AP
antibody from Proteintech Group
Targeting: NCAPD3
CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16828-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16828-1-AP, RRID:AB_2282528
- Product name
- NCAPD3 antibody
- Antibody type
- Polyclonal
- Description
- NCAPD3 antibody (Cat. #16828-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references NCAPD3 is a prognostic biomarker and is correlated with immune infiltrates in glioma.
NCAPD3 promotes diffuse large B-cell lymphoma progression through modulating SIRT1 expression in an H3K9 monomethylation-dependent manner.
Regulation of condensin II by self-suppression and release mechanisms.
NCAPH Stabilizes GEN1 in Chromatin to Resolve Ultra-Fine DNA Bridges and Maintain Chromosome Stability.
Molecular dissection of condensin II-mediated chromosome assembly using in vitro assays.
NCAPG Dynamically Coordinates the Myogenesis of Fetal Bovine Tissue by Adjusting Chromatin Accessibility.
Non-SMC condensin I complex subunit D2 and non-SMC condensin II complex subunit D3 induces inflammation via the IKK/NF-κB pathway in ulcerative colitis.
Qu L, Che H, Zhao J, Lu X, Ren Z, Wu Y, Liu Q, Guan H
Histology and histopathology 2024 Nov;39(11):1473-1484
Histology and histopathology 2024 Nov;39(11):1473-1484
NCAPD3 promotes diffuse large B-cell lymphoma progression through modulating SIRT1 expression in an H3K9 monomethylation-dependent manner.
Lu T, Yang J, Cai Y, Ding M, Yu Z, Fang X, Zhou X, Wang X
Journal of advanced research 2024 Mar 2;
Journal of advanced research 2024 Mar 2;
Regulation of condensin II by self-suppression and release mechanisms.
Yoshida MM, Kinoshita K, Shintomi K, Aizawa Y, Hirano T
Molecular biology of the cell 2024 Feb 1;35(2):ar21
Molecular biology of the cell 2024 Feb 1;35(2):ar21
NCAPH Stabilizes GEN1 in Chromatin to Resolve Ultra-Fine DNA Bridges and Maintain Chromosome Stability.
Kim JH, Youn Y, Hwang JH
Molecules and cells 2022 Nov 30;45(11):792-805
Molecules and cells 2022 Nov 30;45(11):792-805
Molecular dissection of condensin II-mediated chromosome assembly using in vitro assays.
Yoshida MM, Kinoshita K, Aizawa Y, Tane S, Yamashita D, Shintomi K, Hirano T
eLife 2022 Aug 19;11
eLife 2022 Aug 19;11
NCAPG Dynamically Coordinates the Myogenesis of Fetal Bovine Tissue by Adjusting Chromatin Accessibility.
Hu X, Xing Y, Fu X, Yang Q, Ren L, Wang Y, Li Q, Li J, Zhang L
International journal of molecular sciences 2020 Feb 13;21(4)
International journal of molecular sciences 2020 Feb 13;21(4)
Non-SMC condensin I complex subunit D2 and non-SMC condensin II complex subunit D3 induces inflammation via the IKK/NF-κB pathway in ulcerative colitis.
Yuan CW, Sun XL, Qiao LC, Xu HX, Zhu P, Chen HJ, Yang BL
World journal of gastroenterology 2019 Dec 21;25(47):6813-6822
World journal of gastroenterology 2019 Dec 21;25(47):6813-6822
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The NCAPD3 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human NCAPD3. This antibody recognizes human antigen. The NCAPD3 antibody has been validated for the following applications: ELISA, WB analysis.
